Since the overall increase in breast cancer risk seems to be mainly due to an increased incidence of hormone receptor-positive tumors [67], targeted control of risk factors for hormone receptor-positive status in breast cancer may be one of the effective strategies to reduce overall breast cancer incidence. Here, NR4A1 is linked to breast cancer.